Welcome to LookChem.com Sign In|Join Free
  • or
L-Tyrosine, N-benzoyl-O-(phenylmethyl)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

90656-96-5

Post Buying Request

90656-96-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

90656-96-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 90656-96-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,6,5 and 6 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 90656-96:
(7*9)+(6*0)+(5*6)+(4*5)+(3*6)+(2*9)+(1*6)=155
155 % 10 = 5
So 90656-96-5 is a valid CAS Registry Number.

90656-96-5Downstream Products

90656-96-5Relevant academic research and scientific papers

Design, synthesis and evaluation of novel metalloproteinase inhibitors based on l-tyrosine scaffold

Cheng, Xian-Chao,Wang, Run-Ling,Dong, Zhen-Ke,Li, Jing,Li, Yao-Yuan,Li, Rong-Rong

, p. 5738 - 5744 (2012/11/06)

A series of novel l-tyrosine derivatives were designed, synthesized and assayed for their inhibitory activities on matrix metalloproteinase 2 (MMP-2) and histone deacetylase 8 (HDAC-8). The results showed that these l-tyrosine derivatives exhibited inhibitory profiles against MMP-2 and HDAC-8. The compounds 6h (IC50 = 0.013 ± 0.001 μM) and 6j (IC 50 = 0.017 ± 0.001 μM) were equal potent MMP-2 inhibitors to the positive control NNGH (IC50 = 0.014 ± 0.001 μM). As for HDAC-8 inhibition, some of the hydroxamate compounds, such as 6d (IC 50 = 3.6 ± 0.2 μM) and 6c (IC50 = 5.8 ± 0.5 μM), were equal potent to the positive control SAHA (IC50 = 1.6 ± 0.1 μM). Structure-activity relationships were also briefly discussed.

Novel compounds and compositions as protease inhibitors

-

, (2008/06/13)

The present invention relates to novel N-cyanomethyl amides which are cysteine protease inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 90656-96-5